ChitogenX Inc.
CHGX
Pozycja w akcjach
#39857
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Cena akcji
$0.00365786
Ostatnia synchronizacja: 2025-07-07
Kapitalizacja rynkowa
$293.82K
Zmiana (1 dzień)
-0.43%
Zmiana (1 rok)
-28.28%
Kraj
CA
Handel ChitogenX Inc. (CHGX)
Kategoria
Healthcare
Historia ceny akcji dla ChitogenX Inc. (CHGX)
Najwyższa cena zamknięcia: $0.01 dnia 2026-10-01
Najniższa cena zamknięcia: $0.46 dnia 2020-10-01
Najniższa cena zamknięcia: $0.46 dnia 2020-10-01
Historia cen akcji firmy ChitogenX Inc. od 2020 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | -53.93% |
| 2024 | -85.54% |
| 2023 | -64.19% |
| 2022 | -43.64% |
| 2021 | -43.08% |
| 2020 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $755.78 | 7.42% |
CH
|
